Work

Differential Responses to Erlotinib in Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Cancers With Acquired Resistance to Gefitinib Carrying the L747S or T790M Secondary Mutations

Year: 2008

Type: letter

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.14.9039

Authors: Daniel B. Costa, Susan T. Schumer, Daniel G. Tenen, Susumu Kobayashi

Institutions: Beth Israel Deaconess Medical Center, Harvard University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Dana-Farber/Harvard Cancer Center SPORE in Lung Cancer

OpenAlex ID: W1965129132

Cites: 7

Cited by: 126

Related to: 10